Search

Author/Creator Martinez, Felipe A.

21. Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure: Is It Ever Too Late to Start a New Therapy?. (December 2020)

Authors:
Yeoh, Su E.; Dewan, Pooja; Jhund, Pardeep S.; Inzucchi, Silvio E.; Køber, Lars; Kosiborod, Mikhail N.; Martinez, Felipe A.; Ponikowski, Piotr; Sabatine, Marc S.; Solomon, Scott D.; Bengtsson, Olof; Sjöstrand, Mikaela; Langkilde, Anna Maria; McMurray, John J.V.
Journal:
Circulation
Issue:
Volume 13:Number 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial. Issue 14 (6th March 2023)

Authors:
Kondo, Toru; Jering, Karola S.; Borleffs, C. Jan Willem; de Boer, Rudolf A.; Claggett, Brian L.; Desai, Akshay S.; Dobreanu, Dan; Inzucchi, Silvio E.; Hernandez, Adrian F.; Janssens, Stefan P.; Jhund, Pardeep S.; Kosiborod, Mikhail N.; Lam, Carolyn S.P.; Langkilde, Anna Maria; Martinez, Felipe A....
Journal:
Circulation
Issue:
Volume 147:Issue 14(2023)
Page Start:
1067
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Rationale and design of the AFFIRM‐AHF trial: a randomised, double‐blind, placebo‐controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron‐deficient patients admitted for acute heart failure. (28th December 2019)

Authors:
Ponikowski, Piotr; Kirwan, Bridget‐Anne; Anker, Stefan D.; Dorobantu, Maria; Drozdz, Jarosław; Fabien, Vincent; Filippatos, Gerasimos; Haboubi, Teba; Keren, Andre; Khintibidze, Irakli; Kragten, Hans; Martinez, Felipe A.; McDonagh, Theresa; Metra, Marco; Milicic, Davor; Nicolau, José C.; Ohlsson, ...
Journal:
European journal of heart failure
Issue:
Volume 21:Number 12(2019)
Page Start:
1651
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER. Issue 8 (7th November 2022)

Authors:
Wang, Xiaowen; Vaduganathan, Muthiah; Claggett, Brian L.; Hegde, Sheila M.; Pabon, Maria; Kulac, Ian J.; Vardeny, Orly; O'Meara, Eileen; Zieroth, Shelley; Katova, Tzvetana; McGrath, Martina M.; Pouleur, Anne-Catherine; Jhund, Pardeep S.; Desai, Akshay S.; Inzucchi, Silvio E.; Kosiborod, Mikhail N...
Journal:
Circulation
Issue:
Volume 147:Issue 8(2023)
Page Start:
624
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics. (15th July 2019)

Authors:
McMurray, John J.V.; DeMets, David L.; Inzucchi, Silvio E.; Køber, Lars; Kosiborod, Mikhail N.; Langkilde, Anna Maria; Martinez, Felipe A.; Bengtsson, Olof; Ponikowski, Piotr; Sabatine, Marc S.; Sjöstrand, Mikaela; Solomon, Scott D.
Journal:
European journal of heart failure
Issue:
Volume 21:Number 11(2019)
Page Start:
1402
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗